NYTNYT·3hHealth
score+0.70
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Original
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
“Headline emphasizes FDA approval and patient advocacy success with hopeful language ('promising,' 'early access') despite cancer context.”